Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlethora Solutions Holdings Plc Regulatory News (PLE)

  • There is currently no data for PLE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - Plethora Solutions PLC

24 Feb 2016 08:50

RNS Number : 9883P
Peel Hunt LLP
24 February 2016
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Peel Hunt LLP

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Plethora Solutions Holdings PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

Regent Pacific Group Limited

(d) Date dealing undertaken:

23 February 2016

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ordinary Shares

Buy

375,929

3.45 GBx

3.03 GBx

Ordinary Shares

Sale

479,032

3.60 GBx

3.40 GBx

 

 

 (b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:/

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

Date of disclosure:

24 February 2016

Contact name:

Paul Crispin

Telephone number:

0207 418 8988

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERVZLBLQLFZBBK
Date   Source Headline
15th Mar 20132:57 pmRNSHolding(s) in Company
25th Feb 201311:07 amRNSStrategic review of The Urology Company Limited
14th Feb 20137:00 amRNSFinancing Update
5th Feb 201312:24 pmRNSRelated Party Transaction
5th Feb 20138:19 amRNSFinancing Update
7th Nov 20124:58 pmRNSHolding(s) in Company
28th Sep 20127:00 amRNSHalf Yearly Report
29th Jun 201211:55 amRNSReport & Accounts
29th Jun 20127:00 amRNSTotal Voting Rights
26th Jun 20125:15 pmRNSHolding(s) in Company
15th Jun 20124:11 pmRNSIssue of Equity - Directors' Interest
14th Jun 201212:05 pmRNSSubscription of Shares
24th Apr 201212:00 pmRNSChange of Registered Office
29th Mar 20127:00 amRNSPreliminary Results
15th Mar 20127:00 amRNSPSD502 Regulatory Submission Update
23rd Jan 20127:01 amRNSTrading Statement
20th Jan 20127:00 amRNSProduct Launch
6th Jan 20127:00 amRNSDirectorate Change
19th Dec 20117:00 amRNSProduct Update
31st Oct 20116:04 pmRNSTotal Voting Rights
14th Oct 20111:23 pmRNSResult of General Meeting
30th Sep 20117:00 amRNSHalf Yearly Report
28th Sep 20117:00 amRNSProposed Financing & Reduction of Debt
28th Sep 20117:00 amRNSAmendment to PSD502 Agreements
25th Jul 20117:00 amRNSStriant® SR commercial update
20th Jul 201112:09 pmRNSTrading Update
6th Jul 20111:24 pmRNSResult of AGM
24th Jun 20112:36 pmRNSReport and Accounts
20th Jun 20117:00 amRNSRe Agreement
9th Jun 201110:00 amRNSResignation of Dr Steven Powell
4th May 20117:00 amRNSExpansion of UK Sales Force
3rd May 20113:48 pmRNSTotal Voting Rights
28th Apr 20114:02 pmRNSDirector/PDMR Shareholding
28th Apr 20112:00 pmRNSHolding(s) in Company
20th Apr 20114:05 pmRNSResult of EGM
15th Apr 20117:00 amRNSHyalofemme Product Update
1st Apr 20117:00 amRNSFinal Results
1st Apr 20117:00 amRNSPlacing
14th Mar 20117:00 amRNSRe Agreement
11th Mar 20112:52 pmRNSDirectorate Change
24th Feb 201112:02 pmRNSHolding(s) in Company
3rd Feb 20119:48 amRNSDirector/PDMR Shareholding
3rd Feb 20117:00 amRNSTrading Update
28th Jan 20113:47 pmRNSHolding(s) in Company
22nd Dec 20104:42 pmRNSHolding(s) in Company
20th Dec 201010:24 amRNSResult of Meeting
20th Dec 20107:00 amRNSExpansion of Product Portfolio
3rd Dec 20107:05 amRNSBusiness Update & Proposed Placing
3rd Dec 20107:00 amRNSProduct Update
17th Nov 20107:01 amRNSLaunch of 3 New Products

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.